Daejeon, South Korea

Chung-Hyun Cho

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2010-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Chung-Hyun Cho

Introduction

Chung-Hyun Cho is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of therapeutic angiogenesis, with a focus on innovative methods for treating various medical conditions. With a total of 3 patents to his name, Cho's work is paving the way for advancements in medical treatments.

Latest Patents

One of his latest patents is a method for inducing angiogenesis in an infarcted heart by administering a coiled coil chimeric molecule. This application discloses a method of treating diseases that are treatable by therapeutic angiogenesis. It involves administering an effective amount of a chimeric coiled coil molecule that comprises a coiled-coil domain linked to a receptor binding domain of a ligand. Another significant patent is a method of treating a cutaneous wound using a coiled coil chimeric molecule. Similar to his previous work, this application also focuses on administering a chimeric coiled coil molecule to treat diseases through therapeutic angiogenesis.

Career Highlights

Chung-Hyun Cho is currently associated with Aprogen Inc., where he continues to innovate and develop new therapeutic methods. His work is instrumental in advancing medical science and improving patient outcomes.

Collaborations

Cho collaborates with various professionals in his field, including his coworker Gou Young Koh. Their combined expertise contributes to the success of their projects and the advancement of medical technologies.

Conclusion

Chung-Hyun Cho's innovative work in therapeutic angiogenesis showcases his dedication to improving medical treatments. His patents reflect a commitment to advancing healthcare solutions, making him a significant figure in the field of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…